# McKesson

Type: Company (MCK)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/mckesson
Canonical HTML page: https://gethealthbrief.com/entity/mckesson

## Recent coverage (1 stories)

### NovoCure’s $655M Revenue Signals a Shift in Direct-to-Patient Cancer Care
2026-06-28 04:07:26 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Amgen and NovoCure represent two extremes in healthcare delivery: a wholesale-dependent drug giant and a patient-centric device innovator. The comparison reveals how direct-to-patient models are reshaping oncology treatment accessibility and reimbursement dynamics.
Full story: https://gethealthbrief.com/story/novocure-direct-patient-model-healthcare-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.